The HIPAA Privacy Rule is a set of United States federal regulations governing the use and disclosure of identifiable health information by specified health-care organizations and their service providers. Issued under the Health Insurance Portability and Accountability Act of 1996 (HIPAA), it establishes protections for health information while permitting information flows needed for treatment, payment, health-care administration, and certain public purposes. It also gives individuals rights concerning access to their records, corrections, and information about privacy practices. The rule is not a general prohibition on sharing medical information and does not cover every organization that possesses health-related data.
Legal basis and development
HIPAA directed the federal government to establish standards for electronic health-care transactions and related safeguards. Its administrative simplification provisions provided the statutory basis for federal health-information privacy regulations.
The Department of Health and Human Services (HHS) issued the original final Privacy Rule in December 2000 and modified it in 2002. Most covered entities were required to comply by April 14, 2003; small health plans had an additional year. Its principal requirements appear in Title 45 of the Code of Federal Regulations, Parts 160 and 164, particularly Part 164, Subpart E.
The Health Information Technology for Economic and Clinical Health Act of 2009 strengthened the HIPAA framework, including enforcement and obligations affecting business associates. A major implementing measure, commonly called the 2013 Omnibus Rule, revised the privacy, security, breach-notification, and enforcement regulations.
The Privacy Rule is one component of this framework. The separate HIPAA Security Rule establishes administrative, physical, and technical safeguards for electronic protected health information. The Breach Notification Rule addresses notification following breaches of unsecured protected health information. These rules interact but impose distinct obligations.
Who and what the rule covers
Covered entities and business associates
The Privacy Rule applies principally to three categories of covered entities:
- Health plans, including many private health insurers, employer-sponsored group health plans, and government health coverage programs.
- Health-care clearinghouses, which process health information between standard and nonstandard transaction formats.
- Health-care providers that electronically transmit health information in connection with transactions for which HHS has adopted standards, such as specified billing transactions.
Not every health-care provider is necessarily a covered entity.
A business associate is generally a person or organization that performs certain functions or services for a covered entity involving protected health information. Examples include some billing companies, records-management services, consultants, and cloud-service providers. Subcontractors performing relevant functions may also be business associates.
Covered entities generally must obtain contractual assurances that business associates will protect information appropriately. Business associates also have direct legal obligations under specified HIPAA provisions. A contract alone does not make every service provider a business associate; the actual function and information involved matter.
Protected health information
Protected health information (PHI) is, broadly, individually identifiable health information held or transmitted by a covered entity or business associate, subject to defined exclusions. It can concern a person’s past, present, or future physical or mental health, the provision of health care, or payment for health care.
The Privacy Rule covers PHI in electronic, paper, and oral form. A diagnosis, bill, recorded conversation, or appointment record may qualify when connected to an identifiable individual.
Important exclusions include certain education records governed by federal education-privacy law and employment records held by a covered entity in its capacity as an employer. Information about a person who has been deceased for more than 50 years is excluded from PHI.
Uses and disclosures
The rule distinguishes use, generally involving information within an organization, from disclosure, which involves providing access to information outside that organization.
Its central structure is that covered entities may use or disclose PHI only as permitted or required by the rule, or pursuant to a valid authorization from the individual.
Treatment, payment, and health-care operations
Covered entities generally may use or disclose PHI without a separate HIPAA authorization for:
- Treatment, including providing, coordinating, or managing health care.
- Payment, including claims processing and activities to obtain reimbursement.
- Health-care operations, including defined quality assessment, administrative, compliance, and related activities.
These permissions have conditions and do not override every other applicable confidentiality requirement. A permitted disclosure is not necessarily a required disclosure.
Other permitted disclosures
The rule permits disclosures for specified purposes beyond ordinary care and payment. Depending on the provision, these may include public health activities, health oversight, disclosures required by law, certain judicial proceedings, and defined law-enforcement purposes.
These are conditional permissions rather than unrestricted exceptions. For example, different requirements apply to a court order, a subpoena without a court order, and a law-enforcement request.
Limited disclosures may also be made to family members or others involved in an individual’s care or payment for care. The applicable conditions depend on circumstances such as the individual’s agreement, opportunity to object, presence, and capacity to make decisions. Family relationship alone does not establish an unlimited right to records.
Authorization and minimum necessary information
Uses and disclosures not otherwise permitted generally require a valid written authorization. Authorizations must contain specified elements and ordinarily can be revoked prospectively. Particularly restrictive rules apply to most uses and disclosures of separately maintained psychotherapy notes, and to certain marketing activities and sales of PHI.
For many activities, covered entities must make reasonable efforts to limit PHI to the minimum necessary to accomplish the intended purpose. This standard has important exceptions, including disclosures to, or requests by, health-care providers for treatment, disclosures to the individual, and uses or disclosures made under a valid authorization.
Individual rights
The rule creates several rights concerning health information, although each has defined limits.
Access to records
Individuals generally have a right to inspect and obtain copies of PHI in a designated record set. This includes medical and billing records and other records used, wholly or partly, to make decisions about individuals. It does not necessarily include every document held by an organization.
The general response period is 30 calendar days, with one additional 30-day extension permitted when specified notice requirements are satisfied. Certain information, including psychotherapy notes as defined by the rule, is excluded from the access right. Some denials are subject to review.
Fees for copies are restricted to permitted, reasonable, cost-based charges. The access right does not depend on whether the individual has paid outstanding treatment bills.
Amendment and disclosure accounting
Individuals may request an amendment to information in a designated record set. A covered entity may deny a request on specified grounds, including that the information is accurate and complete. The process does not create an unrestricted right to erase or rewrite medical records; individuals may submit a statement of disagreement following certain denials.
Individuals may also request an accounting of certain disclosures. This is not a comprehensive list of every person who accessed a record. The standard accounting requirement excludes several categories, including most disclosures for treatment, payment, and health-care operations.
Notices, restrictions, and confidential communications
Covered entities subject to the notice requirement must provide a notice of privacy practices describing relevant uses, disclosures, duties, and individual rights. Acknowledging receipt of this notice is distinct from authorizing a disclosure.
Individuals may request restrictions on certain uses or disclosures, but covered entities generally need not agree. An important exception concerns specified disclosures to a health plan for payment or operations when an item or service has been paid for in full out of pocket and the disclosure is not otherwise required by law.
The rule also provides rights to request confidential communications through alternative means or at alternative locations, subject to applicable conditions.
Research and de-identification
The Privacy Rule permits the use of health information for medical research through several pathways. These include individual authorization, a qualifying waiver approved by an institutional review board or privacy board, and specified provisions for preparatory research and research involving deceased individuals.
Information properly de-identified under the rule is no longer PHI. The rule recognizes two methods:
- Expert determination, using accepted statistical and scientific principles to determine that identification risk is very small.
- Safe harbor, requiring removal of specified identifiers and the absence of actual knowledge that the remaining information could identify an individual.
Removing a name alone does not necessarily de-identify a record. De-identification under HIPAA is a defined legal standard, not a guarantee that re-identification is technically impossible.
A limited data set may retain certain information excluded by safe harbor, such as some dates and geographic details. It remains PHI and may be used or disclosed for specified purposes under a data use agreement.
Administration and enforcement
Covered entities must implement appropriate privacy policies, workforce training, safeguards, complaint procedures, and documentation practices. They must designate a privacy official and prohibit retaliation against individuals for exercising protected rights or filing complaints.
HHS’s Office for Civil Rights is the principal federal civil enforcement body. Enforcement can involve complaint investigations, compliance reviews, corrective action, settlements, and civil monetary penalties. Certain wrongful conduct involving identifiable health information may also result in criminal prosecution.
HIPAA does not itself create a general private right for individuals to sue for damages. Related conduct may nevertheless support claims under other applicable laws, depending on the circumstances.
Relationship to other laws and limits
HIPAA operates within a broader system of data privacy and health-confidentiality protections. It generally preempts contrary state requirements, but important exceptions preserve certain state laws, including laws that provide more stringent privacy protection. Other federal confidentiality laws may impose additional requirements, such as those governing certain substance-use-disorder patient records.
Unlike the General Data Protection Regulation in the European Union, HIPAA is primarily sectoral rather than a general framework covering personal information across the economy. Its application depends heavily on who holds the information and in what capacity.
Consequently, health information held by a consumer application, wearable-device company, employer, or other organization may fall outside HIPAA. A provider of a consumer service may become subject to relevant HIPAA obligations when it performs qualifying functions as a business associate, but health-related content alone does not establish coverage. Other consumer protection and privacy laws may still apply.
Privacy Rule compliance is also distinct from cybersecurity. Unauthorized viewing of a paper chart or an inappropriate oral disclosure can raise privacy issues without a computer-security incident. Conversely, technical safeguards alone do not establish that an organization’s uses and disclosures of health information are legally permitted.